Tofacitinib prevents depressive-like behaviors through decreased hippocampal microgliosis and increased BDNF levels in both LPS-induced and CSDS-induced mice. - Gao YN; Pan KJ; Zhang YM; Qi YB; Chen WG; Zhou T; Zong HC; Guo HR; Zhao JW; Liu XC; Cao ZT; Chen Z; et al. (Acta pharmacologica Sinica, 2025)